- Home
- UVE vs KURA Comparison
UVE vs KURA Comparison
Compare UVE & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UVE | KURA |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.6M | 841.6M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | UVE | KURA |
|---|---|---|
| Price | $36.91 | $10.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $40.00 | $25.56 |
| AVG Volume (30 Days) | 156.4K | ★ 1.8M |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | ★ 214.43 | N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $1,603,915,000.00 | $67,482,000.00 |
| Revenue This Year | N/A | $28.28 |
| Revenue Next Year | $2.88 | $106.37 |
| P/E Ratio | $20.02 | ★ N/A |
| Revenue Growth | 5.48 | ★ 25.24 |
| 52 Week Low | $21.96 | $5.45 |
| 52 Week High | $41.96 | $12.49 |
Technical Indicators
Market Signals| Indicator | UVE | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 56.79 |
| Support Level | $32.51 | $8.80 |
| Resistance Level | $41.32 | $11.17 |
| Average True Range (ATR) | 1.16 | 0.63 |
| MACD | -0.45 | 0.04 |
| Stochastic Oscillator | 1.98 | 53.80 |
Price Performance
Historical ComparisonAbout UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.